Clinical Trials
85 trialsSCREEN-HPV
UNICANCER
GATEWAY
Sun Yat-sen University
HOPES
Centre Leon Berard
NEO COMBAT XL
UNC Lineberger Comprehensive Cancer Center
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial
Fred Hutchinson Cancer Center
ABY-029 Head & Neck Trial
Dartmouth-Hitchcock Medical Center
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
NRG Oncology
NimoBenSeq
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
RAIN-HNSCC
Sun Yat-sen University
Ficerafusp Alfa, Pembrolizumab, and Stereotactic Body Radiotherapy (SBRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)
Washington University School of Medicine
Neoadjuvant Becotatug Vedotin Plus Pucotenlimab in Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma (OSCC)
Shanghai Zhongshan Hospital
Cyclophosphamide and Etoposide as a Metronomic Therapy in Advanced Head and Neck Squamous Cell Cancer
National Cancer Institute, Egypt
AID-OraL
Assistance Publique - Hôpitaux de Paris
N'FORCE
Groupe Oncologie Radiotherapie Tete et Cou
Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0)
Dana-Farber Cancer Institute
NOCANO
Karolinska University Hospital
Cetuximab Combined With Pembrolizumab or Finotonlimab and Chemotherapy in R/M HNSCC
Fudan University
Hypofractionated Radiotherapy for Postoperative Intermediate-Risk Head and Neck Squamous Cell Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
SELECT-FR
UNICANCER
Nano-Carbon Iron Suspension Injection Combined With Radiotherapy for Solid Tumors Phase II Clinical Trial
Sichuan Enray Pharmaceutical Sciences Company
Low-cost Screening and Image-guided Photodynamic Therapy (PDT) of Premalignant and Malignant Oral Lesions
University of Massachusetts, Boston
SPAR
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)
Vanderbilt-Ingram Cancer Center
Camrelizumab Combined With EGFR Monoclonal Antibody or Chemotherapy for Perioperative Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Lattice-Based Radiotherapy and Chemoimmunotherapy for Oropharyngeal Squamous Cell Carcinoma
NYU Langone Health
BaReTox
Centre Georges Francois Leclerc
SAVED
University of Maryland, Baltimore
p53 RCT
University of British Columbia
H101 Plus TACE for r/m HNSCC
West China Hospital
NeoCamre-HN
National Medical Research Radiological Centre of the Ministry of Health of Russia
Intralesional Chemotherapy (IC): Cisplatin + Epinephrine
University of Miami
Neoadjuvant Becotatug Vedotin Plus Pucotenlimab and Cisplatin for Locally Advanced Head and Neck Squamous Cell Carcinoma
Sir Run Run Shaw Hospital
A Phase II Clinical Trial of Anti-EGFR Antibody-drug Conjugate (ADC) Combined With or Without Immune Checkpoint Inhibitors in the Neoadjuvant Treatment of Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
West China Hospital
PDT For Induction Therapy For Head And Neck Cancer
Massachusetts General Hospital
A Single-arm, Phase II, Multi-center Clinical Trial of Sintilimab During the Perioperative Period in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
Zhejiang Cancer Hospital
Lattice-Based Radiotherapy and Chemo-Immunotherapy for Oral Cavity Squamous Cell Carcinoma
NYU Langone Health
SHINE
Sun Yat-sen University
PIONEER-HN
Sun Yat-sen University
Neo-Margin
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Effectiveness of Hydrogen Water Intervention on Acute Oral Inflammation, Oral Microbiota, and Pain Following Free Flap Reconstruction in Patients With Oral Cancer
Kaohsiung Medical University Chung-Ho Memorial Hospital
Decitabine and Nivolumab in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
Case Comprehensive Cancer Center
[18F]-AraG PET Imaging in LA HNSCC
Indiana University
Adebrelimab Combined With Carboplatin and Albumin-bound Taxanol in the Treatment of Resectable Locally Advanced Oral Squamous Cell Carcinoma Cardiac, Randomized, Phase II Exploratory Study
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Primary Tumor Depth of Invasion and Lymph Node Management in Oral Squamous Cell Carcinoma
Al-Azhar University
PD-1 Inhibitor Therapy Versus Radiotherapy in MPR Patients With Locally Advanced HNSCC After Neoadjuvant Immunochemotherapy (HNC-SYSU-006)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
OSCC
Shanghai Zhongshan Hospital
89Zr-Panitumumab for Assessment of Suspected Metastatic Lesions on 18F-FDG-PET/CT in HNSCC
Stanford University
NCLDR
Qilu Hospital of Shandong University
Comparing Neoadjuvant Chemotherapy Combined With PD-1 Inhibitor Versus Neoadjuvant Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Carcinoma
Fudan University
Chemoimmunotherapy With or Without SBRT Before Surgery for Locally Advanced Oral and Oropharyngeal Cancer
Sun Yat-sen University